Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

Blackweek’s inaugural three-day conference featured several health-focused panels discussing health equity and more inclusive ...

Deal volumes for pharmaceutical deals were lower in 2023 than they were 10 years ago and have been lower, on average, than ...

Shyamakant Giri, a seasoned business leader in pharmaceuticals, appointed as CEO of Gland Pharma effective January 15, 2025.

Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...

Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...

SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.

Shyamakant Giri has been appointed as the new CEO of Gland Pharma, effective January 15, 2025. Giri brings over 25 years of ...

Astellas Pharma's drug Vyloy was approved for treatment of advanced gastric and gastroesophageal junction cancer by the Food and Drug Administration.

India’s exports have faced significant headwinds due to global disruptions, like the tensions in West Asia, continued ...

It’s been a whirlwind year for Joerg Moeller, M.D. After being appointed CEO of BenevolentAI in January, Moeller is now out ...

This week, Johnson & Johnson JNJ began the third-quarter earnings season for the drug and biotech sector. The FDA granted ...